PT

Professor Tennent

Professor Tennent is an internationally recognized researcher with specialist knowledge of antimicrobial resistance mechanisms and the discovery and commercialization of vaccines. Jan has held senior roles at CSIRO, the CRC for Vaccine Technology, CSL, and Pfizer Animal Health (now Zoetis) where she was the Director of Business Development and Global Alliances in the APAC region. Her most recent executive role was as CEO of Biomedical Research Victoria (2012-2019). Jan is also a non-executive director of Agriculture Victoria Services Pty Ltd, Phytogene Pty Ltd, AusBiotech Limited and eviDent Foundation Limited.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AHX
AHX
30/09/240128,323N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AHX
AHX
30/09/24
Buy
2,591$0.485$1,257Dividend Reinvestment Plan (DRP)
AHX
AHX
03/04/24
Buy
3,659$0.333$1,220Dividend Reinvestment Plan (DRP)
AHX
AHX
02/11/23
Buy
50,000$0.280$14,000On-market trade
AHX
AHX
21/10/22
Buy
382$0.749$286Dividend Reinvestment Plan (DRP)
AHX
AHX
24/06/22
Issued
12,360$0.700$8,652Rights issue